MO912: Different Immunogenicity of Previous SARS-COV-2 Infection or Comirnaty Vaccine (BNT162B2, BioNTech/Pfizer) in Haemodialysis Patients
Author(s) -
Guido Gembillo,
Alfio Edoardo Giuffrida,
Vincenzo Labbozzetta,
Rossella Siligato,
Eugenia Spallino,
Giovanna Sposito,
Guido Ferlazzo,
Felicia Cuzzola,
Antonella Lipari,
Vincenzo Calabrese,
Domenico Santoro
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac084.007
Subject(s) - medicine , confidence interval , immunogenicity , dialysis , vaccination , titer , antibody , univariate analysis , multivariate analysis , pandemic , covid-19 , immunology , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom